A series of pharmaceutical companies’ lawsuits… Is it considered as an improper group action?

Recently, domestic pharmaceutical companies in Korea are fearlessly(?) facing lawsuits against the government regarding insurance expenses. They tried to resist against the Ministry of Health and Welfare’s ‘drug price linear reduction’ policy through lawsuits, and ended up even failing to begin with or withdrawing them two years ago; however, they are having a totally different situation this t...